NEWS & EVENTS
New Corporate Website Online
We are proud to present Alpex new corporate website . The new website is structured in 7 areas of interest,...
Read more
Alpex successfully inspected and approved by FDA for a weight loss ODT (Orally Disintegrating Tablets).
Mezzovico, Switzerland February 28, 2011 – Alpex Pharma SA a Swiss Drug Delivery company and manufacturer of...
Read more
R&D Projects
Alpex Pharma has undertaken extensive development activities for third parties.
It also identifies product opportunities and develops them internally in view of finding interested licensing partners.
Our development plan include drug-excipient compatibility studies, analytical method development, definition of formula, cleaning development, non-pivotal stability studies and reporting.
Projects currently under developement
| Alpex ID Code # A166 |
| Drug category: |
Mucolythic |
Prescription: |
OTC |
| Dosage form: |
Effervescent tablets |
License granted: |
Available |
| Indication: |
Cold and Cought |
Free available territories: |
Worldwide |
| Alpex ID Code # A153 |
| Drug category: |
NSAID |
Prescription: |
RX |
| Dosage form: |
ODT |
License granted: |
Few EU & Asian Counties |
| Indication: |
Artritis Reumatoide |
Free available territories: |
Rest of the world |
| Alpex ID Code # A152 |
| Drug category: |
Benzodiazepine |
Prescription: |
RX |
| Dosage form: |
ODT |
License granted: |
USA |
| Indication: |
Seizure Disorders & Panic Disorders |
Free available territories: |
Rest of the World |
| Alpex ID Code # A135 |
| Drug category: |
Narcotic |
Prescription: |
RX |
| Dosage form: |
ODT |
License granted: |
USA |
| Indication: |
Breakthrough Pain (buccal) |
Free available territories: |
Rest of the World |